The transformative impact of rapid in-house next-generation sequencing (NGS) technology on cancer treatment is becoming increasingly evident. This advancement is particularly significant in enabling personalized medicine and improving patient outcomes. With the progress in molecular testing and the
Gene therapy, a revolutionary approach to treating and preventing diseases by modifying faulty genes, relies heavily on accurate measurement techniques. Ensuring the safety and efficacy of these treatments necessitates precise quantification of adeno-associated virus (AAV) vectors, which deliver
The U.S. Department of Defense has awarded a substantial grant of $11.9 million to the Oregon State University (OSU) College of Pharmacy, with the aim of developing advanced drug delivery technologies specifically designed to protect military personnel from various health threats encountered in
Imagine a world where getting vaccinated no longer means facing a needle and syringe, but instead, involves a simple patch applied to the skin. This prospect is rapidly becoming a reality thanks to the innovative work of the University of Queensland (UQ) and Brisbane-based biotech company Vaxxas.
Aneuploidy, the presence of an abnormal number of chromosomes within a cell, is widely recognized as a defining hallmark of cancer. This association has guided cancer diagnostics and research for years, embedding in the scientific community's understanding of how cancers develop and progress.
Glioblastoma multiforme, an aggressive form of brain cancer, has long been a formidable challenge in the medical field. With patient survival rates stagnating around 15 to 18 months, the need for innovative treatment approaches is critical. NeOnc Technologies, under the leadership of Dr. Thomas
